These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2785444)

  • 21. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Miller WR; Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effects of combinations of cefotaxime or other beta-lactams with rolitetracycline on methicillin-resistant Staphylococcus aureus.
    Kobayashi S; Arai S; Hayashi S
    Jpn J Antibiot; 1989 May; 42(5):1208-15. PubMed ID: 2746860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.
    Varaldo PE; Montanari MP; Biavasco F; Manso E; Ripa S; Santacroce F
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):677-82. PubMed ID: 8243483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of methicillin-resistant Staphylococcus aureus isolated in a Canadian hospital.
    Hammerberg O; Bialkowska-Hobrzanska H; Gregson D; McGhie K; Behme R
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):199-205. PubMed ID: 7614960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus.
    Norris SR; Stratton CW; Kernodle DS
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1649-50. PubMed ID: 7979301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.
    Sierra-Madero JG; Knapp C; Karaffa C; Washington JA
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1754-7. PubMed ID: 3266728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N; Diri MC; Türkyilmaz FR
    Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
    Skov R; Frimodt-Møller N; Espersen F
    APMIS; 2002 Aug; 110(7-8):559-64. PubMed ID: 12390414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
    Farrar WE; Gramling PK
    J Infect Dis; 1976 Jun; 133(6):691-5. PubMed ID: 1047087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1993 Sep; 32(3):431-44. PubMed ID: 8262865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.
    Catherall EJ; Gillon V; Hurn S; Irwin R; Mizen L
    Antimicrob Agents Chemother; 1992 Feb; 36(2):458-62. PubMed ID: 1605610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.